Edwards Lifesciences Corporation (BIT:1EW)
62.01
0.00 (0.00%)
At close: Apr 16, 2025, 5:30 PM CET
Edwards Lifesciences Revenue
In the year 2024, Edwards Lifesciences had annual revenue of $5.44B USD with 8.57% growth. Edwards Lifesciences had revenue of $1.39B in the quarter ending December 31, 2024, with 9.43% growth.
Revenue
$5.44B
Revenue Growth
+8.57%
P/S Ratio
7.01
Revenue / Employee
$344.27K
Employees
15,800
Market Cap
36.85B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.44B | 429.50M | 8.57% |
Dec 31, 2023 | 5.01B | 546.00M | 12.23% |
Dec 31, 2022 | 4.46B | -768.50M | -14.69% |
Dec 31, 2021 | 5.23B | 846.20M | 19.29% |
Dec 31, 2020 | 4.39B | 38.30M | 0.88% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Intesa Sanpaolo | 25.38B |
UniCredit | 23.99B |
Enel SpA | 78.95B |
Ferrari | 6.68B |
Assicurazioni Generali | 55.30B |
Eni S.p.A. | 91.17B |
Leonardo S.p.a. | 17.76B |
Stellantis | 156.88B |